476 related articles for article (PubMed ID: 28130548)
21. β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.
Carr R; Schilling J; Song J; Carter RL; Du Y; Yoo SM; Traynham CJ; Koch WJ; Cheung JY; Tilley DG; Benovic JL
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):E4107-16. PubMed ID: 27354517
[TBL] [Abstract][Full Text] [Related]
22. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
Macia E; Partisani M; Paleotti O; Luton F; Franco M
J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
[TBL] [Abstract][Full Text] [Related]
23. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
24. Single-molecule analysis of ligand efficacy in β
Gregorio GG; Masureel M; Hilger D; Terry DS; Juette M; Zhao H; Zhou Z; Perez-Aguilar JM; Hauge M; Mathiasen S; Javitch JA; Weinstein H; Kobilka BK; Blanchard SC
Nature; 2017 Jul; 547(7661):68-73. PubMed ID: 28607487
[TBL] [Abstract][Full Text] [Related]
25. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
Seifert R; Wenzel-Seifert K; Lee TW; Gether U; Sanders-Bush E; Kobilka BK
J Biol Chem; 1998 Feb; 273(9):5109-16. PubMed ID: 9478963
[TBL] [Abstract][Full Text] [Related]
26. An efficacy-dependent effect of cardiac overexpression of beta2-adrenoceptor on ligand affinity in transgenic mice.
Gürdal H; Bond RA; Johnson MD; Friedman E; Onaran HO
Mol Pharmacol; 1997 Aug; 52(2):187-94. PubMed ID: 9271340
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
Singh M; Moniri NH
Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
[TBL] [Abstract][Full Text] [Related]
28. Discovery of regulators of receptor internalization with high-throughput flow cytometry.
Wu Y; Tapia PH; Fisher GW; Simons PC; Strouse JJ; Foutz T; Waggoner AS; Jarvik J; Sklar LA
Mol Pharmacol; 2012 Oct; 82(4):645-57. PubMed ID: 22767611
[TBL] [Abstract][Full Text] [Related]
29. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations.
Seifert R; Wenzel-Seifert K; Gether U; Kobilka BK
J Pharmacol Exp Ther; 2001 Jun; 297(3):1218-26. PubMed ID: 11356949
[TBL] [Abstract][Full Text] [Related]
30. Development of an Allostery Responsive Chromatographic Method for Screening Potential Allosteric Modulator of Beta2-adrenoceptor from a Natural Product-Derived DNA-Encoded Chemical Library.
Tian R; Yin J; Yao Q; Wang T; Chen J; Liang Q; Li Q; Zhao X
Anal Chem; 2022 Jun; 94(25):9048-9057. PubMed ID: 35695812
[TBL] [Abstract][Full Text] [Related]
31. Structure-based discovery of beta2-adrenergic receptor ligands.
Kolb P; Rosenbaum DM; Irwin JJ; Fung JJ; Kobilka BK; Shoichet BK
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6843-8. PubMed ID: 19342484
[TBL] [Abstract][Full Text] [Related]
32. Structural features of β2 adrenergic receptor: crystal structures and beyond.
Bang I; Choi HJ
Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
[TBL] [Abstract][Full Text] [Related]
33. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.
Weiss DR; Ahn S; Sassano MF; Kleist A; Zhu X; Strachan R; Roth BL; Lefkowitz RJ; Shoichet BK
ACS Chem Biol; 2013 May; 8(5):1018-26. PubMed ID: 23485065
[TBL] [Abstract][Full Text] [Related]
34. Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor.
Reinartz MT; Kälble S; Littmann T; Ozawa T; Dove S; Kaever V; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):51-65. PubMed ID: 25342094
[TBL] [Abstract][Full Text] [Related]
35. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
36. Label-free functional selectivity assays.
Ferrie AM; Goral V; Wang C; Fang Y
Methods Mol Biol; 2015; 1272():227-46. PubMed ID: 25563188
[TBL] [Abstract][Full Text] [Related]
37. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
38. Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the Target.
Brown DG; Brown GA; Centrella P; Certel K; Cooke RM; Cuozzo JW; Dekker N; Dumelin CE; Ferguson A; Fiez-Vandal C; Geschwindner S; Guié MA; Habeshian S; Keefe AD; Schlenker O; Sigel EA; Snijder A; Soutter HT; Sundström L; Troast DM; Wiggin G; Zhang J; Zhang Y; Clark MA
SLAS Discov; 2018 Jun; 23(5):429-436. PubMed ID: 29316408
[TBL] [Abstract][Full Text] [Related]
39. Cysteine redox state regulates human β2-adrenergic receptor binding and function.
Rambacher KM; Moniri NH
Sci Rep; 2020 Feb; 10(1):2934. PubMed ID: 32076070
[TBL] [Abstract][Full Text] [Related]
40. Detergent- and phospholipid-based reconstitution systems have differential effects on constitutive activity of G-protein-coupled receptors.
Staus DP; Wingler LM; Pichugin D; Prosser RS; Lefkowitz RJ
J Biol Chem; 2019 Sep; 294(36):13218-13223. PubMed ID: 31362983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
